Epithalon

Overview

Epithalon (also spelled Epitalon) is a synthetic four-amino-acid peptide developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, intended as a simplified, synthesizable analog of Epithalamin, a bovine pineal gland extract studied in earlier Russian aging research. It's one of several short "bioregulator" peptides from the same research program — see also Thymalin, Vilon, Pinealon, Cortagen, and Bronchogen on this site.

Proposed Mechanism of Action

The foundational cited study reports that Epithalon induced telomerase enzymatic activity and telomere elongation in telomerase-negative human fetal fibroblast cell cultures — the proposed mechanism is reactivation of telomerase gene expression in somatic cells, which the authors frame as relevant to cellular aging (the Hayflick limit).

Research Context

This is an in vitro (cell culture) finding, not an animal or human study. It is a specific, narrow result — telomerase activation and telomere elongation in one type of cultured cell — that has since become the basis for much broader claims about Epithalon and aging/longevity circulating outside the primary literature. The primary study itself does not establish organism-level lifespan extension, safety, or dosing in animals or humans.

Limitations of the Current Evidence

• The foundational evidence here is a single in vitro cell-culture study from the peptide's originating research group; we did not find independent replication by unaffiliated laboratories in the sources reviewed for this profile.
• As with Semax and Selank, much of the broader Epithalon literature originates from a small, tightly connected cluster of Russian research institutions, which limits independent verification relative to more widely replicated findings.
• Telomerase activation is itself a biologically double-edged mechanism — it's also implicated in some cancer biology — which the cited study does not address.